Seasonal Pick Recombinant Ebov (subtype Bundibugyo, Strain Uganda 2007) Glycoprotein / Gp-rbd Protein (fc Tag) Limited Time 80% Off [vLeIDzkw]

Recombinant EBOV (Bundibugyo, Uganda 2007) Glycoprotein / GP-RBD Protein (Fc Tag)

The Recombinant EBOV (Bundibugyo, Uganda 2007) Glycoprotein / GP-RBD Protein (Fc Tag) is a highly purified, recombinant protein derived from the Bundibugyo strain of the Ebola virus. This protein is expressed in HEK293 cells and is tagged with a C-hFc, which allows for easy detection and purification. It serves as a powerful research tool for understanding the structure and function of the Ebola virus glycoprotein, particularly the receptor-binding domain (RBD), which is crucial for virus entry into host cells.

• High purity > 95% as determined by reducing SDS-PAGE.
• Expressed in HEK293 cells for consistency and reliability.
• Tagged with C-hFc for enhanced detection and purification.

Product Properties and Specifications

This recombinant protein is produced with exceptional purity, exceeding 95% as determined by reducing SDS-PAGE. It is designed to be highly active and is expressed in HEK293 cells, ensuring consistent and reliable results. The protein sequence covers Met1-Val308, providing a comprehensive representation of the Ebola virus glycoprotein. The calculated molecular weight is 57.6 kDa, making it suitable for various research applications.

• Calculated molecular weight: 57.6 kDa.
• Accession number: ACI28624.1.
• Storage: Lyophilized powder, stable at -20 to -80℃ for up to 12 months.

Applications and Benefits

The Recombinant EBOV (Bundibugyo, Uganda 2007) Glycoprotein / GP-RBD Protein (Fc Tag) is an essential tool for researchers studying the Ebola virus, particularly in the areas of vaccine design, entry inhibitors, and antiviral drug development. It allows for a better understanding of the virus's entry mechanisms and the development of effective treatments. This protein is suitable for use in various research applications, including ELISA, Western blot, and immunofluorescence assays. By using this product, researchers can advance their studies and contribute to the fight against Ebola and other viral diseases.

• Supports research in vaccine design and antiviral drug development.
• Facilitates the study of virus entry mechanisms and immune responses.
• Contributes to the fight against Ebola and other viral diseases.